Soleno Therapeutics (SLNO) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.83
-1.31
-0.79
-0.27

Details

Expected EPS
-0.605
Actual EPS
-1.83
Surprise EPS
-1.23
Surprise Percent
+202.48%

Description

Soleno Therapeutics (SLNO) has reported earnings of -1.83 per share for Q4 2024.

0 Comments

Share your thoughts